Nuevas formas de vehiculización de agentes hipotensores para el tratamiento del glaucoma

  1. Andres Guerrero, Vanessa
Dirigida por:
  1. María del Rocío Herrero Vanrell Director/a
  2. Irene Teresa Molina Martínez Director/a

Universidad de defensa: Universidad Complutense de Madrid

Fecha de defensa: 29 de junio de 2011

Tribunal:
  1. Julián García Feijoo Presidente/a
  2. Beatriz de las Heras Polo Secretario/a
  3. Virginia Merino Sanjuán Vocal
  4. Nicolas Tsapis Vocal
  5. Carmen Álvarez Lorenzo Vocal

Tipo: Tesis

Teseo: 113230 DIALNET

Resumen

Glaucoma is the second leading cause of blin dness in the world. It is a chronic optic neuropathy which can lead to complete loss of vision if an adequate treatment is not used in time. At the moment there is no cure for glaucoma and the available treatments are chronic and only manage to contr ol or decrease the evolution of the pathology. These types of treatments, consisting of the instillation of eye drops once or twice per day, are usually associated to short- and long-term adverse effects that compromise the patient compliance...